UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Clinical trials for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA explained in plain language.
Never miss a new study
Get alerted when new UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA trials appear
Sign up with your email to follow new studies for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New malaria combo shows promise in clearing parasites
Disease control CompletedThis study tested a combination of two anti-malarial drugs, cipargamin and KLU156, in 60 people aged 12 and older with uncomplicated Plasmodium falciparum malaria. The main goal was to see if the drugs could clear the malaria parasite from the blood by day 29 without the infectio…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 07:09 UTC
-
New malaria combo shows promise in kids
Disease control CompletedThis study tested a new combination of two drugs, KAF156 and lumefantrine, in children aged 6 months to 18 years with uncomplicated malaria. The goal was to see if the treatment works well and is safe. The study included 295 children and measured how many were cured by day 29.
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
New malaria pill matches current gold standard in large trial
Disease control CompletedThis study tested a new malaria drug, KLU156, against the standard treatment Coartem in over 1,700 adults and children with uncomplicated malaria. The goal was to see if KLU156 works just as well and is safe. Results showed KLU156 is non-inferior to Coartem, offering a potential …
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New malaria pill shows promise in clearing parasites fast
Disease control CompletedThis study tested a new anti-malarial drug called INE963 in 52 adults with uncomplicated P. falciparum malaria. The main goal was to see how quickly the drug clears malaria parasites from the blood. Researchers also checked the 28-day cure rate and drug safety. The study was comp…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 15:59 UTC